Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xishuangbanna Banna Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of traditional Dai medicines and natural green drugs. Founded in 2002 and based in Jinghong City, Yunnan Province, the company operates as a wholly-owned subsidiary of KPC Pharmaceuticals. Its product portfolio includes several exclusive Dai medicine formulations such as Zhuzi Gantai Capsules for hepatitis B, Shuangjiang Weitong Pills for gastritis, and Yajiao Hadun Powder for colds, alongside chemical drugs like Colchicine tablets for acute gouty arthritis. The company possesses multiple GMP-certified oral solid dosage and extraction production lines, positioning it as a leading enterprise in the regional biopharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xishuangbanna Banna Pharmaceutical.